ES454160A1 - Un procedimiento para la preparacion de nuevas pirazincarbo-xamidas. - Google Patents

Un procedimiento para la preparacion de nuevas pirazincarbo-xamidas.

Info

Publication number
ES454160A1
ES454160A1 ES454160A ES454160A ES454160A1 ES 454160 A1 ES454160 A1 ES 454160A1 ES 454160 A ES454160 A ES 454160A ES 454160 A ES454160 A ES 454160A ES 454160 A1 ES454160 A1 ES 454160A1
Authority
ES
Spain
Prior art keywords
pyrazinecarboxamides
processes
preparing same
eukalemic
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES454160A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES454160A1 publication Critical patent/ES454160A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento de preparación de nuevas pirazincarboxamidas de fórmula: **(Fórmula)** donde R1 es hidrógeno, alquilo inferior de 1 a 5 átomos de carbono, cicloalquilo de 3 a 6 átomos de carbono, alquenilo inferior de 2 a 3 átomos de carbono; R2 es hidrógeno, alquilo inferior de 1 a 5 átomos de carbono; R1 y R2 pueden estar unidos para formar con el átomo de nitrógeno al que están enlazados un anillo heterocíclico de 3 a 6 átomos de carbono; o un anillo heterocíclico con un átomo de nitrógeno adicional además del átomo de nitrógeno al que están unidos R1 y R2; R3 es hidrógeno, alquilo inferior de 1 a 5 átomos de carbono, cicloalquilo de 3 a 6 átomos de carbono en el núcleo.
ES454160A 1975-12-15 1976-12-10 Un procedimiento para la preparacion de nuevas pirazincarbo-xamidas. Expired ES454160A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64080375A 1975-12-15 1975-12-15

Publications (1)

Publication Number Publication Date
ES454160A1 true ES454160A1 (es) 1978-03-01

Family

ID=24569755

Family Applications (2)

Application Number Title Priority Date Filing Date
ES454160A Expired ES454160A1 (es) 1975-12-15 1976-12-10 Un procedimiento para la preparacion de nuevas pirazincarbo-xamidas.
ES465742A Expired ES465742A1 (es) 1975-12-15 1978-01-03 Un procedimiento para la preparacion de nuevas pirazincar- boxamidas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES465742A Expired ES465742A1 (es) 1975-12-15 1978-01-03 Un procedimiento para la preparacion de nuevas pirazincar- boxamidas.

Country Status (14)

Country Link
US (1) US4085211A (es)
JP (1) JPS52106877A (es)
AU (1) AU511429B2 (es)
BE (1) BE849379A (es)
CH (1) CH630369A5 (es)
DE (1) DE2656374A1 (es)
DK (1) DK531476A (es)
ES (2) ES454160A1 (es)
FR (1) FR2335226A1 (es)
GB (1) GB1527297A (es)
HU (1) HU175504B (es)
NL (1) NL7613276A (es)
SE (1) SE431452B (es)
ZA (1) ZA767431B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208413A (en) * 1977-03-04 1980-06-17 Merck & Co., Inc. N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
US4163781A (en) * 1978-04-17 1979-08-07 Merck & Co., Inc. 3-Amino-N-[(phosphonoamino)iminomethyl]-6-halopyrazinecarboxamide compounds, compositions and methods of use
EP0009054A1 (en) * 1978-09-19 1980-04-02 Merck & Co. Inc. N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same
US4272537A (en) * 1980-07-02 1981-06-09 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides
US4277602A (en) * 1980-07-02 1981-07-07 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(3,4-dihydro-6-substituted-1,3,5-truazin-2-yl)2-pyrazinecarboxamides
FI820266L (fi) * 1981-02-02 1982-08-03 Ici Plc Alkanolaminderivater
US4594349A (en) * 1982-01-04 1986-06-10 Beyer Jr Karl H Hyperuretic agents
JPS62291361A (ja) * 1986-06-09 1987-12-18 株式会社ブリヂストン 床支持装置
JPS6342741U (es) * 1986-09-04 1988-03-22
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8812342D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Bicyclic compounds
GB8812343D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Amino compounds
JPH02101937U (es) * 1989-01-31 1990-08-14
AUPP646498A0 (en) * 1998-10-12 1998-11-05 Australian National University, The A method of modulating ion channel functional activity
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AU2005277398A1 (en) 2004-08-18 2006-03-02 Michael R. Johnson Cyclic amide and ester pyrazinoylguanidine sodium channel blockers
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
GB0526244D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
MX2010006421A (es) * 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
DE102008053024B4 (de) 2008-10-24 2015-04-30 RUHR-UNIVERSITäT BOCHUM Verwendung von Amilorid-Derivaten zur Bekämpfung von Insekten und Milben
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CA2895512C (en) 2012-12-17 2021-10-19 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
KR102367765B1 (ko) * 2014-09-18 2022-02-24 닛산 가가쿠 가부시키가이샤 액정 배향제, 액정 배향막, 및 액정 표시 소자

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299931A (es) * 1962-10-30
NL299929A (es) * 1962-10-30

Also Published As

Publication number Publication date
BE849379A (fr) 1977-06-14
NL7613276A (nl) 1977-06-17
FR2335226B1 (es) 1979-03-09
US4085211A (en) 1978-04-18
HU175504B (hu) 1980-08-28
JPS6238350B2 (es) 1987-08-17
JPS52106877A (en) 1977-09-07
CH630369A5 (de) 1982-06-15
AU2018176A (en) 1978-06-08
GB1527297A (en) 1978-10-04
DE2656374C2 (es) 1989-08-10
ES465742A1 (es) 1978-10-01
DK531476A (da) 1977-06-16
SE431452B (sv) 1984-02-06
AU511429B2 (en) 1980-08-21
FR2335226A1 (fr) 1977-07-15
ZA767431B (en) 1978-07-26
SE7613289L (sv) 1977-06-16
DE2656374A1 (de) 1977-06-16

Similar Documents

Publication Publication Date Title
ES465742A1 (es) Un procedimiento para la preparacion de nuevas pirazincar- boxamidas.
AU1722376A (en) Dispersions
GB1537130A (en) 6,9,21-trihalo-steroids of the pregnane series
JPS56158771A (en) Novel heterocyclic substituted pyradinoylguanidine and its manufacture
AU502203B2 (en) Business form
KE3086A (en) Pyrazolo(3,4,6)quinolines
JPS5245434A (en) Retainer
IL48624A0 (en) 2,3-dihydroergolines
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
IE800609L (en) Thiazolinyl-pyrazine carboxamide
AU499105B2 (en) Mine convening arrangement
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
GB1554925A (en) 2,3-methyl-eneprostaglandins
GB1549006A (en) Telephone systems
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
JPS5210285A (en) 11benzoyll33pyrazinyl ureas
NZ179990A (en) 2-aminomethylene-1,2-dihydor-4h-imidazo (1,2-a) (1,4)-benzodiazepin-1-ones
HK30081A (en) 2-ethyl-6-alkoxy-2,3-dihydro-6h-pyran-3-ones
HK74679A (en) 2-heterocyclylalkyl-3,3a-4-5-6-7-hexahydro-3-phenyl-7-benzylidene-2h-indazoles
JPS5123610A (en) Lsm no kidosochi
JPS532883A (en) Two stage system table lifter
JPS51130104A (en) Telephone set
AU487046B2 (en) 2, 5-dihydro-5-oxo-3-furyl) ureas
JPS51100214A (en) lsm noseigyohoho
IE41459L (en) N - hydroxybenzothiazolyl - n - phenyl ureas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202